First Mercantile Trust Co. lowered its position in Steris PLC (NYSE:STE) by 20.1% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 9,069 shares of the medical equipment provider’s stock after selling 2,286 shares during the quarter. First Mercantile Trust Co.’s holdings in Steris were worth $793,000 at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. Meeder Asset Management Inc. increased its stake in shares of Steris by 1,122.4% in the fourth quarter. Meeder Asset Management Inc. now owns 1,198 shares of the medical equipment provider’s stock valued at $104,000 after buying an additional 1,100 shares during the period. Zions Bancorporation acquired a new position in shares of Steris in the third quarter valued at approximately $178,000. Citigroup Inc. acquired a new position in shares of Steris in the second quarter valued at approximately $206,000. Oakbrook Investments LLC acquired a new position in shares of Steris in the fourth quarter valued at approximately $271,000. Finally, GSA Capital Partners LLP acquired a new position in shares of Steris in the third quarter valued at approximately $284,000. 89.63% of the stock is owned by institutional investors.
In related news, VP John Adam Zangerle sold 3,650 shares of the stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $88.00, for a total value of $321,200.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP Sudhir K. Pahwa sold 2,000 shares of the stock in a transaction on Monday, January 29th. The stock was sold at an average price of $92.09, for a total value of $184,180.00. The disclosure for this sale can be found here. 2.55% of the stock is currently owned by corporate insiders.
Steris (NYSE:STE) last posted its quarterly earnings results on Wednesday, February 7th. The medical equipment provider reported $1.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.07 by $0.05. The firm had revenue of $661.90 million for the quarter, compared to analysts’ expectations of $663.17 million. Steris had a return on equity of 11.49% and a net margin of 5.59%. The company’s revenue for the quarter was up 2.3% compared to the same quarter last year. During the same period in the prior year, the business earned $0.98 EPS. sell-side analysts anticipate that Steris PLC will post 4.06 earnings per share for the current fiscal year.
Several research firms have recently issued reports on STE. TD Securities upped their price objective on Steris from C$14.00 to C$16.00 and gave the company a “buy” rating in a research note on Thursday, November 9th. Zacks Investment Research raised Steris from a “hold” rating to a “buy” rating and set a $103.00 price objective for the company in a research note on Tuesday, January 23rd. Raymond James Financial increased their target price on shares of Steris from $95.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, October 16th. Finally, KeyCorp reissued an “overweight” rating and set a $101.00 target price (up previously from $91.00) on shares of Steris in a research report on Thursday, November 2nd. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $80.00.
TRADEMARK VIOLATION NOTICE: This piece was first posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international trademark & copyright law. The original version of this piece can be accessed at https://sportsperspectives.com/2018/02/08/first-mercantile-trust-co-sells-2286-shares-of-steris-plc-ste.html.
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.